July 28, 2014

CAS databases provide millions of journal article references from more than 10,000 major scientific journals worldwide, patent and patent family references from 63 patent authorities around the world, and other reputable web sources.

The following patent record is from the CAplusSM database.

CAPLUS COPYRIGHT 2014 ACS

Patent Number: WO 2014081689
Title: Preparation of N-substituted triazolamines as inhibitors of indoleamine 2,3-dioxygenase
Inventor(s): Boyall, Dean; Davis, Christopher; Dodd, James; Everitt, Simon; Miller, Andrew; Weber, Peter; Westcott, James; Young, Stephen
Patent Assignee(s): Vertex Pharmaceuticals Incorporated, USA
Source: PCT Int. Appl., 95pp. CODEN: PIXXD2
Language: English

Abstract:
The present invention relates to compds. I [n = 0-4; X = halo; Z1-Z3 = CH or N; R1 = halo, CN, 3-7 membered monocyclic fully satd., partially unsatd., or arom. ring contg. 0-3 heteroatoms independently selected from N, O, or S, etc.] useful as inhibitors of indoleamine 2,3-dioxygenase (IDO).  Forty-eight compds. I were prepd.  E.g., a 2-step synthesis of II, starting from 5-amino-2-chloro-benzonitrile and 2-aminoacetonitrile, was described.  Exemplified compds. I were evaluated as inhibitors of IDO1 (data given).  This invention also relates to pharmaceutically acceptable compns. comprising the compds. I; to methods of treating of various diseases, disorders, and conditions using the compds. I; to processes for prepg. I; to intermediates for the prepn. of I; and methods of using the compds. I in in vitro applications.

Please note:  Abstracts and Titles for patent records in CAplus are routinely enhanced to better describe the claimed invention.

 

 View the full-text here.

Recent News

       
    March 17, 2015 | New Content Provides Regulatory
    Professionals with Additional Value
    
    February 9, 2015 | Major New STN Release Delivers
    Essential Biomedical and Patent Content to IP
    Professionals
    
    January 26, 2015
 | Annual MEDLINE Reload on STN
    Features Enhanced Clinical Trial Information and the
    2015 MeSH Thesaurus
                               
  
                                                                     More News >> 

 Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624                                       
 Email: cas-pr@cas.org